Shiva Biogenetic Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in Solan, Himachal Pradesh, India, established in 2005.
2005 Solan, Himachal Pradesh, India Active
Last Updated:
About Shiva Biogenetic Pharmaceuticals Private Limited

Shiva Biogenetic Pharmaceuticals Private Limited, a active private limited company, was established on 16 September 2005 in Solan, Himachal Pradesh, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24032HP2005PTC010765. Registered under ROC Roc Himachal Pradesh. it is unlisted. It has an authorized capital of ₹3.32 Cr and a paid-up capital of ₹2.25 Cr.

It upholds a compliant status. Employing 126 professional, Its leadership includes Kapil Bhardwaj (Director), Kanhaiya Bhardwaj (Director), Shailendra Kumar Singh (Director). Past directors included Vijay Kumar Sinha, Sushila Devi, Parsan Kumar Singh. It holds ₹21.00 Cr open charges and ₹18.46 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Village Manpura, Tehsil Baddi,, Solan, Himachal Pradesh, Solan, Himachal Pradesh, 174101.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24032HP2005PTC010765

  • Registration Number

    010765

  • Incorporation Date

    16 September 2005

  • Authorized Capital

    ₹3.32 Cr

  • Paid-Up Capital

    ₹2.25 Cr

  • ROC Code

    Roc Himachal Pradesh

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 3.32 Cr
  • Paid Up Capital ₹ 2.25 Cr
  • Company Age 20 Year, 5 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 21.00 Cr
  • Satisfied Charges ₹ 18.46 Cr
  • Revenue Growth **** 33.33%
  • Profit Growth **** 1512.24%
  • Ebitda **** 358.76%
  • Net Worth 7.87%
  • Total Assets **** 21.07%
Company report

Shiva Biogenetic Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Shiva Biogenetic Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Shiva Biogenetic Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Kapil Bhardwaj Director 27 Feb 2010 Current
Kanhaiya Bhardwaj Director 31 Dec 2024 Current
Shailendra Kumar Singh Director 02 Feb 2007 Current
Parsan Kumar Singh Director 13 May 2022 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 29 Sep 2010 Past
Pramod Abcsdd Director 31 Dec 2024 Past
Pramod Abcsdd Managing Director 29 Sep 2021 Past
Pramod Abcsdd Director 25 Mar 2013 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Shiva Biogenetic Pharmaceuticals.

Shiva Biogenetic Pharmaceuticals Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 33.33% increase. The company also saw a substantial improvement in profitability, with a 1512.24% increase in profit. The company's net worth moved up by a moderate rise of 7.87%.

Shiva Biogenetic Pharmaceuticals revenue growth over time
Shiva Biogenetic Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
33.33%
*******
*******
*******
*******
Revenue from Operations
*******
34.10%
*******
*******
*******
*******
Total Assets
*******
21.07%
*******
*******
*******
*******
Profit or Loss
*******
1512.24%
*******
*******
*******
*******
Net Worth
*******
7.87%
*******
*******
*******
*******
EBITDA
*******
358.76%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Shiva Biogenetic Pharmaceuticals?

In 2024, Shiva Biogenetic Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹210,000,000.00

Satisfied Charges

₹184,647,000.00

Charges Breakdown by Lending Institutions
  • State Bank Of India : 21.00 Cr
Latest Charge Details
Date Lender Amount Status
26 Nov 2021 State Bank Of India ₹2.00 Cr Open
03 Jan 2018 State Bank Of India ₹19.00 Cr Open
23 Jun 2014 Axis Bank Limited ₹1.60 Cr Satisfied
25 Mar 2010 Others ₹4.00 Cr Satisfied
25 Mar 2010 Axis Bank Limited ₹2.25 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Shiva Biogenetic Pharmaceuticals?

Shiva Biogenetic Pharmaceuticals has a workforce of 126 employees as of Mar 26, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Shiva Biogenetic Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shiva Biogenetic Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Shiva Biogenetic Pharmaceuticals
Recent Activity within the Organization
  • Director Appointment

    Progress on Kanhaiya Bhardwaj was appointed as a Director was appointed as a Director on 31 Dec 2024 & has been associated with this company since 1 year 2 months . was documented.

  • Charges

    A charge with State Bank Of India of Rs. 19.00 Cr registered on 03 Jan 2018 with Charge ID 100162777 was modified on 26 Dec 2024. was recorded as a recent event.

  • Annual General Meeting

    Shiva Biogenetic Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    Shiva Biogenetic Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Himachal Pradesh. was recorded as a recent event.

  • Charges

    Progress on A charge registered on 16 Jan 2009 via Charge ID 10139854 with Director Of Industries Himachal Pradesh was fully satisfied on 19 Jul 2023. was documented.

  • Director Appointment

    Parsan Kumar Singh was appointed as a Director was appointed as a Director on 13 May 2022 & has been associated with this company since 3 years 9 months . was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Shiva Biogenetic Pharmaceuticals Private Limited?

The CIN of Shiva Biogenetic Pharmaceuticals Private Limited is U24032HP2005PTC010765.

Where is Shiva Biogenetic Pharmaceuticals Private Limited headquartered?

Shiva Biogenetic Pharmaceuticals Private Limited is headquartered at Village Manpura, Tehsil Baddi,, Solan, Himachal Pradesh, Solan, Himachal Pradesh, 174101.

When was Shiva Biogenetic Pharmaceuticals Private Limited incorporated?

Shiva Biogenetic Pharmaceuticals Private Limited was incorporated on 16 September 2005.

Who are the current directors of Shiva Biogenetic Pharmaceuticals Private Limited?

The current directors of Shiva Biogenetic Pharmaceuticals Private Limited are

What is the primary industry of Shiva Biogenetic Pharmaceuticals Private Limited?

The primary industry of Shiva Biogenetic Pharmaceuticals Private Limited is Manufacturing.

Is Shiva Biogenetic Pharmaceuticals Private Limited a listed company?

Shiva Biogenetic Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Shiva Biogenetic Pharmaceuticals Private Limited?

The authorized capital of Shiva Biogenetic Pharmaceuticals Private Limited is ₹3.32 Cr, and the paid-up capital is ₹2.25 Cr.

What is the compliance status of Shiva Biogenetic Pharmaceuticals Private Limited?

The compliance status of Shiva Biogenetic Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available